Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study

Fumihiko Kato, Hiroya Takeuchi, Satoru Matsuda, Hirofumi Kawakubo, Tai Omori, Yuukou Kitagawa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: During the treatment of esophageal cancer with curative intent, patients sometimes experience deep vein thrombosis, pulmonary embolism or a central venous catheter-associated thrombus. In this study, we retrospectively reviewed our new-onset esophageal cancer patients and determined the incidence of venous thromboembolism (VTE), the location of the thrombus and the risk factors for VTE. Methods: One hundred and fifty-three patients undergoing treatment with curative intent were reviewed as candidates. The existence of VTE was assessed from the neck to the pelvis with computed tomography at the initial visit, after neo-adjuvant chemotherapy and postoperatively. Results: Twenty-one VTE events (13.7 %) were observed, 16 of which (76.2 %) were suggested to be associated with central venous catheterization. When both the pre-therapeutic plasma fibrinogen and C-reactive protein levels were high (≥350 mg/dL and ≥0.2 µg/mL, respectively), the risk of preoperative VTE and overall VTE were significantly higher than normal (p = 0.040, and p = 0.030, respectively). Adenocarcinoma histology and neck lymph node dissection were the independent risk factors that significantly increased the overall risk of VTE (p = 0.015, and p = 0.017, respectively). Conclusions: This study revealed that the pre-therapeutic plasma fibrinogen level, C-reactive protein level, adenocarcinoma histology and neck lymph node dissection are the risk factors for venous thromboembolism in patients with esophageal cancer undergoing treatment with curative intent.

Original languageEnglish
JournalSurgery Today
DOIs
Publication statusAccepted/In press - 2015 Jun 22

Fingerprint

Venous Thromboembolism
Esophageal Neoplasms
Incidence
Neck
Therapeutics
Lymph Node Excision
C-Reactive Protein
Fibrinogen
Histology
Adenocarcinoma
Thrombosis
Central Venous Catheterization
Central Venous Catheters
Adjuvant Chemotherapy
Pelvis
Pulmonary Embolism
Venous Thrombosis
Tomography

Keywords

  • Esophageal cancer
  • Esophagectomy
  • Venous thromboembolism

ASJC Scopus subject areas

  • Surgery

Cite this

@article{70c9c90639ae40ed804bf55c9a0865c1,
title = "Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study",
abstract = "Purpose: During the treatment of esophageal cancer with curative intent, patients sometimes experience deep vein thrombosis, pulmonary embolism or a central venous catheter-associated thrombus. In this study, we retrospectively reviewed our new-onset esophageal cancer patients and determined the incidence of venous thromboembolism (VTE), the location of the thrombus and the risk factors for VTE. Methods: One hundred and fifty-three patients undergoing treatment with curative intent were reviewed as candidates. The existence of VTE was assessed from the neck to the pelvis with computed tomography at the initial visit, after neo-adjuvant chemotherapy and postoperatively. Results: Twenty-one VTE events (13.7 {\%}) were observed, 16 of which (76.2 {\%}) were suggested to be associated with central venous catheterization. When both the pre-therapeutic plasma fibrinogen and C-reactive protein levels were high (≥350 mg/dL and ≥0.2 µg/mL, respectively), the risk of preoperative VTE and overall VTE were significantly higher than normal (p = 0.040, and p = 0.030, respectively). Adenocarcinoma histology and neck lymph node dissection were the independent risk factors that significantly increased the overall risk of VTE (p = 0.015, and p = 0.017, respectively). Conclusions: This study revealed that the pre-therapeutic plasma fibrinogen level, C-reactive protein level, adenocarcinoma histology and neck lymph node dissection are the risk factors for venous thromboembolism in patients with esophageal cancer undergoing treatment with curative intent.",
keywords = "Esophageal cancer, Esophagectomy, Venous thromboembolism",
author = "Fumihiko Kato and Hiroya Takeuchi and Satoru Matsuda and Hirofumi Kawakubo and Tai Omori and Yuukou Kitagawa",
year = "2015",
month = "6",
day = "22",
doi = "10.1007/s00595-015-1196-1",
language = "English",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer

T2 - a single-institution study

AU - Kato, Fumihiko

AU - Takeuchi, Hiroya

AU - Matsuda, Satoru

AU - Kawakubo, Hirofumi

AU - Omori, Tai

AU - Kitagawa, Yuukou

PY - 2015/6/22

Y1 - 2015/6/22

N2 - Purpose: During the treatment of esophageal cancer with curative intent, patients sometimes experience deep vein thrombosis, pulmonary embolism or a central venous catheter-associated thrombus. In this study, we retrospectively reviewed our new-onset esophageal cancer patients and determined the incidence of venous thromboembolism (VTE), the location of the thrombus and the risk factors for VTE. Methods: One hundred and fifty-three patients undergoing treatment with curative intent were reviewed as candidates. The existence of VTE was assessed from the neck to the pelvis with computed tomography at the initial visit, after neo-adjuvant chemotherapy and postoperatively. Results: Twenty-one VTE events (13.7 %) were observed, 16 of which (76.2 %) were suggested to be associated with central venous catheterization. When both the pre-therapeutic plasma fibrinogen and C-reactive protein levels were high (≥350 mg/dL and ≥0.2 µg/mL, respectively), the risk of preoperative VTE and overall VTE were significantly higher than normal (p = 0.040, and p = 0.030, respectively). Adenocarcinoma histology and neck lymph node dissection were the independent risk factors that significantly increased the overall risk of VTE (p = 0.015, and p = 0.017, respectively). Conclusions: This study revealed that the pre-therapeutic plasma fibrinogen level, C-reactive protein level, adenocarcinoma histology and neck lymph node dissection are the risk factors for venous thromboembolism in patients with esophageal cancer undergoing treatment with curative intent.

AB - Purpose: During the treatment of esophageal cancer with curative intent, patients sometimes experience deep vein thrombosis, pulmonary embolism or a central venous catheter-associated thrombus. In this study, we retrospectively reviewed our new-onset esophageal cancer patients and determined the incidence of venous thromboembolism (VTE), the location of the thrombus and the risk factors for VTE. Methods: One hundred and fifty-three patients undergoing treatment with curative intent were reviewed as candidates. The existence of VTE was assessed from the neck to the pelvis with computed tomography at the initial visit, after neo-adjuvant chemotherapy and postoperatively. Results: Twenty-one VTE events (13.7 %) were observed, 16 of which (76.2 %) were suggested to be associated with central venous catheterization. When both the pre-therapeutic plasma fibrinogen and C-reactive protein levels were high (≥350 mg/dL and ≥0.2 µg/mL, respectively), the risk of preoperative VTE and overall VTE were significantly higher than normal (p = 0.040, and p = 0.030, respectively). Adenocarcinoma histology and neck lymph node dissection were the independent risk factors that significantly increased the overall risk of VTE (p = 0.015, and p = 0.017, respectively). Conclusions: This study revealed that the pre-therapeutic plasma fibrinogen level, C-reactive protein level, adenocarcinoma histology and neck lymph node dissection are the risk factors for venous thromboembolism in patients with esophageal cancer undergoing treatment with curative intent.

KW - Esophageal cancer

KW - Esophagectomy

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84931863549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931863549&partnerID=8YFLogxK

U2 - 10.1007/s00595-015-1196-1

DO - 10.1007/s00595-015-1196-1

M3 - Article

C2 - 26094966

AN - SCOPUS:84959132104

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

ER -